ISPOR-FDA Summit 2020 Will Focus on the Use of Patient-Preference Information in Medical Devices

Published Jan 28, 2020

March 31 Summit to Offer In-Person and Virtual Registration

Lawrenceville, NJ, USA—January 28, 2020—ISPOR—the professional society for health economics and outcomes research, announced that it will be holding a joint ISPOR-FDA Summit, “Using Patient-Preference Information in Medical Device Regulatory Decisions: Benefit-Risk and Beyond.”

Jointly sponsored by ISPOR and the US Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH), this event will focus on medical devices and the use of patient-preference information in regulatory and other decision-making processes. The Summit will be held on March 31, 2020 at the FDA White Oak Campus in Silver Spring, MD, USA.

Patient-preference information is increasingly being used in regulatory decision making for medical devices. The ISPOR-FDA Summit will provide a forum to engage key stakeholders, including patient representatives, the medical device industry, researchers, payers and policymakers, healthcare providers, assessors, and regulators to discuss and explore the role, challenges, and opportunities of using patient-preference information across the healthcare ecosystem.

Summit speakers currently confirmed include: Michelle Tarver, MD, PhD, Center for Devices and Radiological Health, FDA; Anindita Saha, MS, Center for Devices and Radiological Health, FDA; David Gebben, PhD, Center for Devices and Radiological Health, FDA; Ryan Fischer, Parent Project Muscular Dystrophy; Suzanne Schrandt, JD, ExPPect, LLC; Juan Marcos Gonzalez, PhD, Duke University School of Medicine; Brett Hauber, PhD, RTI Health Solutions; Shelby Reed, RPh, PhD, Duke Clinical Research Institute; Ravishankar Jayadevappa, PhD, University of Pennsylvania Perelman School of Medicine; Dean Bruhn-Ding, RAC, CVRx, Inc; Dan Harfe, Tusker Medical, Inc; Bennett Levitan, MD, PhD, Janssen Research and Development; Barry R. Liden, Edwards Lifesciences; and Todd Snell, Fresenius Medical Care North America.

Summit registration is complimentary. This initiative offers several options for engagement and learning:

In Person Registration* – March 31, 2020
At the FDA White Oak Campus, Silver Spring, MD, USA
*Seating limited to 300 attendees. Registration for in-person event on first come, first served basis.

Virtual Registration** – March 31, 2020
Via Livestream
**Capacity limited to 1000 attendees. Registration for livestream on first come, first served basis.

A pre-event webinar, “Patient-Preference Information – What It Is and What It Is Not,” is also being offered prior to and in preparation for the ISPOR-FDA Summit 2020. This webinar offers content on using patient-preference information in medical device regulatory decisions. The webinar is open to all and registration is also complimentary.

Pre-Event Webinar***: “Patient-Preference Information – What It Is and What It Is Not
March 4, 2020 at 12:00 Noon (EST)
***Open to all (including non-Summit registrants) and optional for Summit attendees. Please note: On the day of the scheduled webinar, the first 500 registered participants will be accepted into the webinar. For those who are unable to attend or would like to review the webinar at a later date, the full-length webinar recording will be made available at the ISPOR Educational Webinar Series webpage approximately 2 weeks after the scheduled webinar. Reservations are on a first come, first served basis.

Additional information on the ISPOR-FDA Summit 2020 can be found at:
ISPOR-FDA Summit 2020  |  Summit Program  |  Registration Information   |  Press



ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Web: | LinkedIn: | Twitter: (@ISPORorg) | YouTube: | Facebook: | Instagram:

Related Stories

Virtual ISPOR 2020 Begins Next Week

May 11, 2020

ISPOR confirmed the program today for Virtual ISPOR 2020, "HEOR: Advancing Evidence to Action.” The virtual conference is offering nearly 60 hours of content that registrants can attend live and/or on demand through June 30, 2020.

ISPOR Announces Virtual ISPOR 2020

Apr 6, 2020

ISPOR announced that its annual, international conference has been reimagined due to the COVID-19 pandemic and will now take place as a virtual conference.

ISPOR Europe 2019 Convened More Than 5500 Healthcare Stakeholders in the Society’s Largest Conference To Date

Nov 7, 2019

ISPOR concluded its ISPOR Europe 2019 conference yesterday in Copenhagen, Denmark. The conference convened more than 5500 global healthcare stakeholders and HEOR thought leaders representing more than 90 countries. The record attendance of ISPOR Europe 2019 marks the Society’s largest conference to date.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now